Tag cancer
Merck in Advanced Talks to Buy Seagen in Nearly US$ 40 Billion Deal
Merck & Co is in advanced talks to buy cancer-focused biotech company Seagen Inc in a deal that could be worth roughly US$ 40 billion.
Kamis, 07 Juli 2022 | 18:58 WIB
Novartis Wins US Approval for Targeted Cancer Drug Combination
A targeted oral drug combination by Novartis won US approval for use in a wide range.
Kamis, 23 Juni 2022 | 16:38 WIB
GSK to Buy Sierra Oncology for US$ 1.9 Billion in Boost to Blood Cancer Business
The price represents a 39% premium to Tuesday's closing price.
